ASPI

ASP Isotopes Inc.

2026-01-16 06:37 PM

+4.21%

ASP Isotopes continues gains following Renergen deal completion

ASPI extended its rally for a second consecutive day following the January 15th completion of its $5 million acquisition of a 10% stake in Renergen's Tetra4 subsidiary. The deal includes ASPI's commitment to help secure $750 million in expansion funding for South Africa's first commercial liquid helium plant.

Analysis

This appears to be continued momentum from yesterday's positive reaction to the Renergen deal news, which drove a similar gain. The two-day rally of roughly 10% combined suggests investors are still digesting the strategic implications of ASPI's entry into helium production. For context, this follows a pullback earlier in the week, and the stock is now recovering those losses.

Sources

ASP Isotopes Inc. (ASPI) closes Renergen deal, unlocking $750M in funding for helium expansion

Date: 2026-01-16

Price: $7.79

Type: Stock Specific

Confidence: medium